Company intelligence / Profile preview

EverZinc

Ownership: Private
Development stage: Other

Overview

EverZinc is a global chemical manufacturer specializing in zinc chemicals, including GMP Pharma Grade zinc oxide, which serves as an API and excipient for pharmaceuticals. They operate 14 production facilities across North America, Europe, and Asia, catering to industries such as pharmaceuticals, personal care, batteries, paints, and rubber. Founded in 2011, the company is committed to sustainability and is backed by Aterian Investment Partners.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on EverZinc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EverZinc.